[go: up one dir, main page]

MX2016010037A - Nanosuspension de materiales naturales y metodo de preparacion del mismo. - Google Patents

Nanosuspension de materiales naturales y metodo de preparacion del mismo.

Info

Publication number
MX2016010037A
MX2016010037A MX2016010037A MX2016010037A MX2016010037A MX 2016010037 A MX2016010037 A MX 2016010037A MX 2016010037 A MX2016010037 A MX 2016010037A MX 2016010037 A MX2016010037 A MX 2016010037A MX 2016010037 A MX2016010037 A MX 2016010037A
Authority
MX
Mexico
Prior art keywords
nanosuspension
preparation
same
natural materials
natural material
Prior art date
Application number
MX2016010037A
Other languages
English (en)
Other versions
MX375742B (es
Inventor
Brand Werner
Original Assignee
Apurano Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apurano Pharmaceuticals Gmbh filed Critical Apurano Pharmaceuticals Gmbh
Publication of MX2016010037A publication Critical patent/MX2016010037A/es
Publication of MX375742B publication Critical patent/MX375742B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/748—Cyanobacteria, i.e. blue-green bacteria or blue-green algae, e.g. spirulina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/071—Agaricus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/20—Ingredients acting on or related to the structure
    • A23V2200/25—Nanoparticles, nanostructures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente descripción se refiere a un método para la preparación de una nanosuspensión de al menos un material natural, en el que el método comprende las etapas de (a) proporcionar al menos un material natural que tiene un tamaño de partícula (D90) de menos de 320 µm; (b) dispersar dicho al menos un material natural de la etapa (a) en un disolvente; y (c) moler la dispersión de la etapa (b) a un tamaño de partícula (D90) inferior a 1000 nm. La nanosuspensión es útil para la preparación de un medicamento.
MX2016010037A 2014-02-03 2015-02-03 Nanosuspension de materiales naturales y metodo de preparacion del mismo. MX375742B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14153705 2014-02-03
EP2014064449 2014-07-07
PCT/EP2015/052202 WO2015114164A1 (en) 2014-02-03 2015-02-03 Nanosuspension of natural materials and preparation method thereof

Publications (2)

Publication Number Publication Date
MX2016010037A true MX2016010037A (es) 2017-10-26
MX375742B MX375742B (es) 2025-03-06

Family

ID=52444306

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016010037A MX375742B (es) 2014-02-03 2015-02-03 Nanosuspension de materiales naturales y metodo de preparacion del mismo.

Country Status (22)

Country Link
US (1) US10213382B2 (es)
EP (1) EP3102185B1 (es)
JP (2) JP6751672B2 (es)
KR (1) KR20160118317A (es)
CN (1) CN106102719A (es)
AU (1) AU2015212726B2 (es)
CA (1) CA2938552C (es)
CY (1) CY1124656T1 (es)
DK (1) DK3102185T3 (es)
ES (1) ES2891151T3 (es)
HR (1) HRP20211513T1 (es)
HU (1) HUE056398T2 (es)
LT (1) LT3102185T (es)
MX (1) MX375742B (es)
NZ (1) NZ723631A (es)
PL (1) PL3102185T3 (es)
RS (1) RS62381B1 (es)
RU (1) RU2695325C1 (es)
SA (1) SA516371597B1 (es)
SI (1) SI3102185T1 (es)
WO (1) WO2015114164A1 (es)
ZA (1) ZA201604743B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX375742B (es) * 2014-02-03 2025-03-06 Apurano Pharmaceuticals Gmbh Nanosuspension de materiales naturales y metodo de preparacion del mismo.
WO2017021491A1 (en) * 2015-08-04 2017-02-09 Apurano Life Sciences Gmbh Nanosuspension containing particles and extract of natural materials
JP6664770B1 (ja) * 2018-03-27 2020-03-13 株式会社Ｍｉｚｋａｎ Ｈｏｌｄｉｎｇｓ 植物含有固体脂組成物、その製造方法及び外観・食味の改善方法
EP3813876A1 (en) * 2018-07-10 2021-05-05 Applied Lifesciences and Systems, LLC Method of preparing and delivering oocyst solutions
CN109432018A (zh) * 2018-12-25 2019-03-08 中国人民解放军第四军医大学 难溶性药物的纳米混悬液及其制备方法和应用
KR102116022B1 (ko) * 2019-07-16 2020-05-27 (주)코이즈 고농도의 산소를 함유하는 미세소구체가 포함된 화장료 조성물 및 이의 제조방법
ES2938493T3 (es) 2020-01-06 2023-04-11 Cannaxan Gmbh Preparación y uso de nanoformulación de cannabis
CN115998703B (zh) * 2022-12-14 2024-09-06 迪沙药业集团有限公司 一种地榆组合物及其制备方法
US11832614B1 (en) 2023-04-28 2023-12-05 King Faisal University Method of inhibiting mycotoxin growth using Arthrospira platensis nanoparticles

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3502153A1 (de) 1985-01-23 1986-07-24 Röben Kolloid Entwicklung GmbH & Co KG, 2932 Zetel Kolloidator zum kolloidieren von fliessfaehigen materialien
DE4137540A1 (de) 1991-11-14 1993-05-19 Steigerwald Arzneimittelwerk Verwendung von praeparaten der curcuma-pflanzen
JPH05221852A (ja) 1992-02-18 1993-08-31 L T T Kenkyusho:Kk 制ガン剤の新規製剤調製方法
ZA9711731B (en) * 1996-12-31 1998-07-01 Monsanto Co Aqueous glycerol formulations of somatotropin
US20050107582A1 (en) 2003-07-30 2005-05-19 Alfred Wong Method for the preparation of phytosterols from tall oil pitch
US20120042886A1 (en) * 1998-03-11 2012-02-23 Hanna Piskorz Method of producing a nicotine medicament and a medicament made by the method
DE19832304A1 (de) * 1998-07-17 2000-01-20 Reiner Weichert Verfahren und Vorrichtung zur Ultrafein-Mahlung von festen Materialien
US6375986B1 (en) * 2000-09-21 2002-04-23 Elan Pharma International Ltd. Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
MXPA02000053A (es) 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
JP3633601B2 (ja) 2001-04-27 2005-03-30 味の素株式会社 免疫賦活剤
JP4752233B2 (ja) 2001-04-27 2011-08-17 味の素株式会社 免疫賦活剤
JP2005508345A (ja) * 2001-09-28 2005-03-31 グライコメッド・サイエンシーズ・リミテッド 溶媒抽出法
CN1416847A (zh) * 2001-11-07 2003-05-14 焦柏忠 纳米级西洋参制品及其制作方法
IL146737A (en) * 2001-11-26 2010-02-17 Lycored Natural Prod Ind Ltd Method for protecting lycopene dispersed in tomato fibers
US20060233845A1 (en) * 2002-02-28 2006-10-19 Gerold Lukowski Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics
EP1511468A1 (en) * 2002-06-10 2005-03-09 Elan Pharma International Limited Nanoparticulate sterol formulations and sterol combinations
US20120156309A1 (en) * 2007-09-19 2012-06-21 Eckert C Edward Using Aqueous Oxygenation to Improve Animal Health & Wellness
US20060062926A1 (en) * 2004-05-17 2006-03-23 Richardson H W Use of sub-micron copper salt particles in wood preservation
KR20080003322A (ko) * 2005-02-24 2008-01-07 엘란 파마 인터내셔널 리미티드 도세탁셀 및 이의 유사체의 나노입자 배합물
DE102005011786A1 (de) * 2005-03-11 2006-09-14 Pharmasol Gmbh Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
CN100341785C (zh) * 2005-07-27 2007-10-10 湖州吴兴恒联碳酸钙厂 亚微米级重质碳酸钙的制备方法
JP5374869B2 (ja) 2007-12-25 2013-12-25 三菱化学株式会社 セルロース繊維複合体
EP2226171B1 (en) 2007-12-21 2019-04-10 Mitsubishi Chemical Corporation Fiber composite
ES2613865T3 (es) 2008-03-17 2017-05-26 Suntory Beverage & Food Limited Agente mejorador del gusto y bebida de té que contiene el mismo
JP5448511B2 (ja) 2008-03-31 2014-03-19 三栄源エフ・エフ・アイ株式会社 ウコン色素組成物及びその調製方法
JP2010083839A (ja) 2008-10-02 2010-04-15 Sanei Gen Ffi Inc ミルクカルシウムの分散安定化方法並びにその製剤
KR101160801B1 (ko) * 2010-05-27 2012-06-29 서용일 고형 보조 첨가제
US9468657B2 (en) * 2010-06-08 2016-10-18 Asahi Group Holdings, Ltd. Lactic acid bacterium agent for improving lipid metabolism
TWI425914B (zh) * 2011-03-21 2014-02-11 Food Industry Res & Dev Inst 含高濃度奈米／次微米疏水性機能化合物之水相分散液之製備方法
MX341663B (es) * 2012-05-11 2016-08-30 Activus Pharma Co Ltd Nanopolvo de compuesto organico, metodo para producirlo y su suspension.
MX375742B (es) * 2014-02-03 2025-03-06 Apurano Pharmaceuticals Gmbh Nanosuspension de materiales naturales y metodo de preparacion del mismo.
CA2944471C (en) * 2014-04-08 2020-03-31 Sansa Corporation (Barbados) Inc. Nicotine formulations and methods of making the same

Also Published As

Publication number Publication date
CY1124656T1 (el) 2022-07-22
DK3102185T3 (da) 2021-10-04
CA2938552C (en) 2021-07-13
KR20160118317A (ko) 2016-10-11
HRP20211513T1 (hr) 2021-12-24
CA2938552A1 (en) 2015-08-06
LT3102185T (lt) 2022-01-10
RS62381B1 (sr) 2021-10-29
AU2015212726A1 (en) 2016-09-15
ES2891151T3 (es) 2022-01-26
AU2015212726B2 (en) 2018-02-01
SI3102185T1 (sl) 2022-01-31
SA516371597B1 (ar) 2020-04-29
WO2015114164A1 (en) 2015-08-06
CN106102719A (zh) 2016-11-09
US20160346201A1 (en) 2016-12-01
EP3102185B1 (en) 2021-07-14
NZ723631A (en) 2017-08-25
MX375742B (es) 2025-03-06
JP2017505814A (ja) 2017-02-23
PL3102185T3 (pl) 2021-12-27
JP2018172394A (ja) 2018-11-08
HUE056398T2 (hu) 2022-02-28
JP6751672B2 (ja) 2020-09-09
ZA201604743B (en) 2017-09-27
EP3102185A1 (en) 2016-12-14
US10213382B2 (en) 2019-02-26
RU2695325C1 (ru) 2019-07-23

Similar Documents

Publication Publication Date Title
MX2016010037A (es) Nanosuspension de materiales naturales y metodo de preparacion del mismo.
CL2017000288A1 (es) Encapsulación de compuestos hidrofóbicos biologicamente activos
EP3224657A4 (en) Materials, components, and methods for use with extreme ultraviolet radiation in lithography and other applications
MA39883A (fr) Particules inorganiques individualisées
EP3148925A4 (en) Graphene quantum dot-polymer composites and methods of making the same
BR112017027638A2 (pt) método e configuração de instalação para a preparação e ativação de uma matéria-prima
EP3120460A4 (en) Chips including classical and quantum computing processors
EP3156156A4 (en) Fine silver particle dispersion, fine silver particles, and method for producing same
EP3068821A4 (en) Uv-curable silicone composition, cured products thereof, and methods of using the same
EP3150550A4 (en) Method for producing carbon nanotube dispersion and carbon nanotube dispersion, method for producing composition for composite material and method for producing composite material, and composite material and composite material molded article
BR112015025353A2 (pt) processo para a produção de um material polimérico compósito, material polimérico compósito, produto polimérico, e, uso de um material polimérico compósito
MX2016006916A (es) Composicion farmaceutica, que comprende particulas de aglutinante de fosfato.
AR088160A1 (es) Proceso de oligomerizacion
EP3178789A4 (en) Organic solvent dispersion of zirconium oxide particles and method for producing same
EP3081966A4 (en) Polymerizable composition for optical materials, optical material and method for producing same
EP3228640A4 (en) Curable composition containing semiconductor nanoparticles, cured product, optical material and electronic material
EP3222667A4 (en) Spherical monodispersible polyester resin aqueous dispersion, method for producing same, spherical monodispersible polyester resin particle, and cosmetic product
EP3135703A4 (en) Polymerizable composition for optical material, optical material, and method for producing optical material
EP3239099A4 (en) Carbon nanotube film and method for producing same
EP3263651A4 (en) Dispersion of titanium oxide particles in organic solvent, and production method for same
AR096167A1 (es) Clasificador
MX375799B (es) Preparación de absorbedores de uv de tamaño nanométrico.
MX2019002823A (es) Metodo de reciclaje de alto desempeño, de un solo recipiente para residuo de polímero usando síntesis de polímero renovable.
WO2016096085A8 (en) Particles for electrophoretic displays
BR112016019863A2 (pt) Material compósito de fibra natural orgânica reforçado, processo para fazer o material compósito, e, uso de um material compósito

Legal Events

Date Code Title Description
FG Grant or registration